|
1
|
Govindan R, Page N, Morgensztern D, Read
W, Tierney R, Vlahiotis A, Spitznagel EL and Piccirillo J: Changing
epidemiology of small-cell lung cancer in the United States over
the last 30 days: Analysis of the surveillance, epidemiologic, and
end results database. J Clin Oncol. 24:4539–4544. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van Meerbeeck JP, Fennell DA and De
Ruysscher DK: Small-cell lung cancer. Lancet. 378:1741–1755. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jett JR, Schild SE, Kesler KA and
Kalemkerian GP: Treatment of small cell lung cancer: Diagnosis and
management of lung cancer, 3rd edn: American College of Chest
Physicians evidence-based clinical practice guidelines. Chest. 143
(Suppl 5):e400S–e419S. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Früh M, De Ruysscher D, Popat S, Crinò L,
Peters S and Felip E; ESMO Guidelines Working Group, : Small-cell
lung cancer (SCLC): ESMO Clinical Practice Guidelines for
diagnosis, treatment and follow-up. Ann Oncol. 24 (Suppl
6):vi99–vi105. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eckert F and Muller AC: SCLC-extensive
disease-treatment guidance by extent or/and biology of response?
Radiat Oncol. 3:332008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kalemkerian GP: Advances in
pharmacotherapy of small cell lung cancer. Expert Opin
Pharmacother. 15:2385–2396. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Riess JW and Lara PN Jr: Left behind? Drug
discovery in extensive-stage small-cell lung cancer. Clin Lung
Cancer. 15:93–95. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Glatzer M, Schmid S, Radovic M, Früh M and
Putora PM: The role of radiation therapy in the management of small
cell lung cancer. Breathe (Sheff). 13:e87–e94. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeremic B, Shibamoto Y, Nikolic N, Milicic
B, Milisavljevic S, Dagovic A, Aleksandrovic J and
Radosavljevic-Asic G: Role of radiation therapy in the
combined-modality treatment of patients with extensive disease
small-cell lung cancer. a randomized study. J Clin Oncol.
17:2092–2099. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giuliani ME, Atallah S, Sun A, Bezjak A,
Le LW, Brade A, Cho J, Leighl NB, Shepherd FA and Hope AJ: Clinical
outcomes of extensive stage small cell lung carcinoma patients
treated with consolidative thoracic RT. Clin Lung Cancer.
12:375–379. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu H, Zhou Z, Wang Y, Bi N, Feng Q, Li J,
Lv J, Chen D, Shi Y and Wang L: Thoracic radiation therapy improves
the overall survival of patients with extensive-stage small cell
lung cancer with distant metastasis. Cancer. 117:5423–5431. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yee D, Butts C, Joy A, Smylie M, Fenton D,
Chu Q, Hanson J and Roa W: Clinical trial of post-chenotherapy
consolidation thoracic radiotherapy for extensive-stage small cell
lung cancer. Radiother Oncol. 102:234–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Slotman BJ, van Tinteren H, Praag JO,
Knegjens JL, El Sharouni SY, Hatton M, Keijser A, Faivre-Finn C and
Senan S: Use of thoracic RT for extensive stage small-cell lung
cancer: A phase 3 randomised controlled trial. Lancet. 385:36–42.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Masters GA: Clinical presentation of
small-cell lung cancerPass HI, Carbone DP, Johnson DH, Minna JD,
Scagliotti GV and Turrissi AT: Principles and practice of lung
cancer: The official reference text of the international
association for the study of lung cancer (IASLC). 4th. Lippincot
Williams and Wilkins; Philadelphia: pp. 341–352. 2010
|
|
15
|
Stenbygaard LE, Sørensen JB, Larsen H and
Dombernowsky P: Metastatic pattern in non-resectable non-small cell
lung cancer. Acta Oncol. 38:993–998. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kagohashi K, Satoh H, Ishikawa H, Ohtsuka
M and Sekizawa K: Liver metastasis at the time of initial diagnosis
of lung cancer. Med Oncol. 20:25–28. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nakazawa K, Kurishima K, Tamura T,
Kagohashi K, Ishikawa H, Satoh H and Hizawa N: Specific organ
metastases and survival in small cell lung cancer. Oncol Lett.
4:617–620. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Horn L, Castellanos EL and Johnson DH:
Update on new drugs in small cell lung cancer. Expert Opin Investig
Drugs. 20:441–445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lara PN Jr, Natale R, Crowley J, Lenz HJ,
Redman MW, Carleton JE, Jett J, Langer CJ, Kuebler JP, Dakhil SR,
et al: Phase III trial of irinotecan/cisplatin compared with
etoposide/cisplatin in extensive-stage small-cell lung cancer:
Clinical and pharmacogenomic results from SWOG S0124. J Clin Oncol.
27:2530–2535. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Koinis F, Agelaki S, Karavassilis V,
Kentepozidis N, Samantas E, Peroukidis S, Katsaounis P, Hartabilas
E, Varthalitis II, Messaritakis I, et al: Second-line pazopanib in
patients with relapsed and refractory small-cell lung cancer: A
multicentre phase II study of the Hellenic oncology research group.
Br J Cancer. 117:8–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shamp S, Patel RB and Biswas T: Palliative
radiation therapy in extensive stage small cell lung cancer
(ES-SCLC): A survival, epidemiology and end results (SEER)
analysis. Int J Radit Oncol Biol. 99:e4952017. View Article : Google Scholar
|
|
22
|
Surveillance, Epidemiology, and End
Results (SEER) Program (www.seer.cancer.gov) Research Data
(1975–2016), National Cancer Institute, DCCPS, Surveillance
Research Program, released April 2019, based on the November 2018
submission.
|
|
23
|
Goldstraw P, Crowley J, Chansky K, Giroux
DJ, Groome PA, Rami-Porta R, Postmus PE, Rusch V and Sobin L;
International Association for the Study of Lung Cancer
International Staging Committee; Participating Institutions, : The
IASLC Lung Cancer Staging Project: Proposals for the revision of
the TNM stage groupings in the forthcoming (seventh) edition of the
TNM Classification of malignant tumours. J Thorac Oncol. 2:706–714.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
O'Brien ME, Ciuleanu TE, Tsekov H, Shparyk
Y, Cuceviá B, Juhasz G, Thatcher N, Ross GA, Dane GC and Crofts T:
Phase III trial comparing supportive care alone with supportive
care with oral topotecan in patients with relapsed small-cell lung
cancer. J Clin Oncol. 24:5441–5447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Froeschl S, Nicholas G, Gallant V and
Laurie SA: Outcomes of second-line chemotherapy in patients with
relapsed extensive small cell lung cancer. J Thorac Oncol.
3:163–169. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu C, Li F and Jiao SC: Prognostic factors
for survival of patients with extensive stage small cell lung
cancer-a retrospective single institution analysis. Asian Pac J
Cancer Prev. 13:4959–4962. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tas F, Aydiner A, Topuz E, Camlica H, Saip
P and Eralp Y: Factors influencing the distribution of metastases
and survival in extensive disease small cell lung cancer. Acta
Oncol. 38:1011–1015. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bydder S, Spry NA, Christie DR, Roos D,
Burmeister BH, Krawitz H, Davis S, Joseph DJ, Poulsen M and Berry
M: A prospective trial of short-fractionation RT for the palliation
of liver metastases. Australas Radiol. 47:284–288. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Soliman H, Ringash J, Jiang H, Singh K,
Kim J, Dinniwell R, Brade A, Wong R, Brierley J, Cummings B, et al:
Phase II trial of palliative RT for hepatocellular carcinoma and
liver metastases. J Clin Oncol Off J Am Soc Clin Oncol.
31:3980–3986. 2013. View Article : Google Scholar
|
|
30
|
Morikawa K, Mineshita M, Nishine H, Furuya
N, Obayashi J and Miyazawa T: A case of squamous cell lung
carcinoma with bone metastasis responding to denosumab after
zoledronic acid hydrate. Jap J Lung Cancer. 52:1035–1040. 2012.
View Article : Google Scholar
|
|
31
|
Khuntia D, Brown P, Li J and Mehta MP:
Whole-brain radiotherapy in the management of brain metastasis. J
Clin Oncol. 24:1295–1304. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zabel A and Debus J: Treatment of brain
metastases from non-small-cell lung cancer (NSCLC): Radiotherapy.
Lung Cancer. 45 (Suppl 2):S247–S252. 2004. View Article : Google Scholar : PubMed/NCBI
|
